Blog Band - Page 261 of 299

24

Vaccines play an important role in maintaining public health. They reduce the likelihood of infections and save the lives of countless individuals and even entire communities. Vaccines given on the…

20

Jan 2022

TOP 20

Top 20 Biopharma M&A of 2021 by Total Deal Value

Shots: Biopharma merger and acquisition activity continued under the radar with smaller deals through 2021. Despite the absence of eagerly-awaited mega-merger, there were a number of deals above $1 billion.…

19

Jan 2022

INSIGHTS+

Insights+: Key Takeaways of J.P. Morgan Healthcare Conference 2022 Based on Therapeutic Areas

Shots: The 40th Annual J.P. Morgan Healthcare Conference took place virtually on Jan 10-13, 2022. The premier conference is the most extensive and most informative health care investment symposium in…

18

Jan 2022

VIEWPOINTS

PharmaShots Interview: GSK’s Thomas C. Corbridge Shares Insights on the New Survey Data for Severe Eosinophilic Asthma Patients

In an interview with PharmaShots, Thomas C. Corbridge, US Senior Medical Lead at GSK shares his views on the new survey and demonstrated dissatisfaction with the asthma treatment paradigm Shots: The survey was commissioned by GSK and…

17

Jan 2022

VIEWPOINTS

PharmaShots Interview: Janssen’s Nikki Longwell Shares Insights on the National Biologic Coordinators Day

In an interview with PharmaShots, Nikki Longwell, Sr. Director, Medical Science Liaisons, Immunology at Janssen shares her views on the launch of the National Biologic Coordinators Day supporting the needs of people living with autoimmune…

13

Jan 2022

INSIGHTS+

Deal Maker of the Year 2021 (Part 02)

Shots: Roche was at the top with 32 deals for a total announced deal value of ~$25.83B with multiple biopharma companies The highest value deal was Roche’s AI pact with…

12

Jan 2022

VIEWPOINTS

PharmaShots Interview: Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine

In an interview with PharmaShots, Brian Ward, Medical Officer at Medicago shares his views on the P-III study of plant-based COVID-19 vaccine in combination with GSK’s pandemic adjuvant for the treatment of COVID-19 Shots: The company reported efficacy and…

11

Jan 2022

VIEWPOINTS

PharmaShots Interview: Insmed’s Martina Flammer Shares Insights on New Affordable Drugs for Rare Diseases

In an interview with PharmaShots, Martina Flammer, Chief Medical Officer at Insmed share her views on the R&D continuum to develop new drugs for rare diseases and also highlights its business pillars Shots: The idea of the…

10

Jan 2022

SPOTLIGHT

Spotlight Interview with Chris Dokomajilar, CEO and Founder of DealForma

On January 10, 2022, PharmaShots has launched a new section in its interview series: Spotlight - Company of the Month Company of the month is our new exclusive feature under…

07

Jan 2022

INSIGHTS+

Deal Maker of the Year 2021 (Part 01)

Shots: AstraZeneca and Roche were the top dealmakers completed 33 deals with multiple pharma and biotech companies and universities for a total deal value of $6.2B & $25.83B The highest…

The Ultimate Guide To COVID-19 Vaccines: Before, During, And After Vaccination

Top 20 Biopharma M&A of 2021 by Total Deal Value

Insights+: Key Takeaways of J.P. Morgan Healthcare Conference 2022 Based on Therapeutic Areas

PharmaShots Interview: GSK’s Thomas C. Corbridge Shares Insights on the New Survey Data for Severe Eosinophilic Asthma Patients

PharmaShots Interview: Janssen’s Nikki Longwell Shares Insights on the National Biologic Coordinators Day

Deal Maker of the Year 2021 (Part 02)

PharmaShots Interview: Medicago’s Brian Ward Shares Insights on the Data of Plant-Based COVID-19 Vaccine

PharmaShots Interview: Insmed’s Martina Flammer Shares Insights on New Affordable Drugs for Rare Diseases

Spotlight Interview with Chris Dokomajilar, CEO and Founder of DealForma

Deal Maker of the Year 2021 (Part 01)

Contact US

OUR INFORMATION

FOLLOW US